Find clinical trials for Pancreatic Cancer in Orlando, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Orlando, FL, USA:
receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...
Orlando, Florida, United States and 12 other locations
and clinical activity of AB680 in combination with Zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...
Phase 1
Orange City, Florida, United States and 17 other locations
This study is an open-label, international, multi-center, Phase 1 study in adult patients with solid tumors likely to express CLDN18.2....
Phase 1
Orlando, Florida, United States and 19 other locations
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer...
Phase 3
Orange City, Florida, United States and 116 other locations
A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS or EGFR mutations to determine the maximum tolerated d...
Phase 1
Orlando, Florida, United States and 11 other locations
A Phase 1/2 study of MRTX1133 in solid tumors harboring a KRAS G12D mutation....
Phase 1, Phase 2
Lady Lake, Florida, United States and 15 other locations
activity of MOMA-313 administered orally as a single agent or combination therapy in patients with homologous recombinant deficient solid tumors...
Phase 1
Lake Mary, Florida, United States and 6 other locations
as PK and pharmacodynamics of XL309 (previously ISM3091) administered alone or in combination with olaparib in subjects with advanced solid tumors...
Phase 1
Orlando, Florida, United States and 11 other locations
The purpose of this study is to evaluate the efficacy and safety of zanidatamab for the treatment of participants with previously treated solid tumors...
Phase 2
Orlando, Florida, United States and 1 other location
This is a Phase 1/2, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with a...
Phase 1, Phase 2
Orlando, Florida, United States and 20 other locations
Clinical trials
Research sites
Resources
Legal